Advanced Medical Equipment
Varian Medical Systems Inc Receives FDA 510(k) Clearance Of Its Nexus DRF Digital X-Ray Imaging System
Varian Medical Systems Inc announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Varian's diagnostic X-ray image processing workstation that combines radio frequency (RF) and digital radiography (DR) capabilities on one platform. Varian's Nexus DRF Digital X-Ray...
Covidien PLC Announces Clinical Trial Data Showing Endoscopic Ablation Therapy Eliminates Precancerous Esophageal Tissue And Significantly Reduces Disease Progression
Covidien PLC announced that results from a prospective, multicenter, randomized, controlled clinical trial show that endoscopic ablation therapy using the Barrx RF Ablation System is effective at eliminating Barrett`s esophagus, a pre-cancerous condition of the esophagus, and preventing disease...
Hologic Inc Receives FDA Approval For New Low-dose 3D Mammography (Breast Tomosynthesis) Solution For Breast Cancer Screening
Hologic Inc announced that the U.S. Food and Drug Administration (FDA) approved the use of Hologic's new C-View 2D imaging software. C-View 2D images may be used in place of the conventional 2D exposure previously required as part of a Hologic 3D mammography (breast tomosynthesis) screening exam.
Echo Therapeutics Inc Announces Institutional Review Board (IRB) Approval For Clinical Trial Of Symphony CGM System
Echo Therapeutics Inc announced that the Company's clinical trial of Symphony CGM System has received Institutional Review Board (IRB) approval. The IRB approval enables the commencement of a clinical evaluation of Symphony that will support the Company's CE Mark Technical File.
Mergers & Acquisitions
Markets
- Sectors
- U.S.
- Europe
- Asia
Sector Summary
| Energy |  -0.87% |
| Basic Materials | -0.46% |
| Industrials | -1.04% |
| Cyclical Goods & Services | -0.89% |
| Non-Cyclical Goods & Services | -0.14% |
| Financials | -1.18% |
| Healthcare | -0.04% |
| Technology | -1.23% |
| Telecoms | -1.15% |
| Utilities | -1.38% |
| DOW | 15,307.17 | -80.41 |
-0.52% |
| S&P 500 | 1,655.35 | -13.81 |
-0.83% |
| NASDAQ | 3,463.30 | -38.82 |
-1.11% |
| TR US Index | 150.04 | -1.43 |
-0.94% |
+36.40Upcoming Events
No related earnings announcements are currently scheduled within the next 7 days.
Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Renaissance Capital
|
$92.00
|
|
Provider: Renaissance Capital
|
$92.00
|
|
Provider: Renaissance Capital
|
$92.00
|
|
Provider: Renaissance Capital
|
$92.00
|
|
Provider: Renaissance Capital
|
$92.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
